Krystal Biotech

-$1.54 (-2.65%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. is a gene therapy company, which engages in developing and commercializing treatment for patients suffering from dermatological diseases. It developed a gene therapy platform, which company refer to as the Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases.

CEO

Krish S. Krishnan

Employees

Headquarters

Pittsburgh, Pennsylvania

Founded

2016

KRYS Key Statistics

Market Cap

1.42B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

165.07K

High Today

$59.03

Low Today

$56.02

Open Price

$57.80

Volume

47.80K

52 Week High

$87.29

52 Week Low

$39.39

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

KRYS Earnings

-$0.74

-$0.49

-$0.25

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 17, Pre-Market